CoChat

Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment—Part 2

Open access
Evans, Denis A., Grodstein, Francine, Loewenstein, David, Kaye, Jeffrey, Weintraub, Sandra · 2011 · Alzheimer's & Dementia
Cited by 55

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Dementia of the Alzheimer's type (DAT) is a major public health threat in developed countries where longevity has been extended to the eighth decade of life. Estimates of prevalence and incidence of DAT vary with what is measured, be it change from a baseline cognitive state or a clinical diagnostic endpoint, such as Alzheimer's disease. Judgment of what is psychometrically “normal” at the age of 80 years implicitly condones a decline from what is normal at the age of 30. However, because cognitive aging is very heterogeneous, it is reasonable to ask “Is ‘normal for age’ good enough to screen for DAT or its earlier precursors of cognitive impairment?” Cost containment and accessibility of ascertainment methods are enhanced by well‐validated and reliable methods such as screening for cognitive impairment by telephone interviews. However, focused assessment of episodic memory, the key symptom associated with DAT, might be more effective at distinguishing normal from abnormal cognitive aging trajectories. Alternatively, the futuristic “Smart Home,” outfitted with unobtrusive sensors and data storage devices, permits the moment‐to‐moment recording of activities so that changes that constitute risk for DAT can be identified before the emergence of symptoms.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jalz.2010.11.008

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Cited by

See all 55

Metadata

Authors
Evans, D. A., Grodstein, F., Loewenstein, D., Kaye, J., & Weintraub, S.
Venue
Alzheimer's & Dementia
Publisher
Wiley
Published
2011-01
Volume
7
Issue
1
Pages
110-123
ISSN
  • 1552-5260 (ISSN-L)
  • 1552-5279
OpenAlex
W1981612428
Cited by
55
References
32
FWCI
4.92
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment—Part 2. https://app.cochat.ai/papers/10.1016/j.jalz.2010.11.008
The paper
Evans, D. A., Grodstein, F., Loewenstein, D., Kaye, J., & Weintraub, S. (2011). Reducing case ascertainment costs in U.S. population studies of Alzheimer's disease, dementia, and cognitive impairment—Part 2. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2010.11.008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.